- Home
- INFU vs HELP Comparison
INFU vs HELP Comparison
Compare INFU & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INFU | HELP |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | Canada |
| Employees | N/A | 50 |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.8M | 233.0M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | INFU | HELP |
|---|---|---|
| Price | $9.19 | $7.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $15.00 | ★ $51.50 |
| AVG Volume (30 Days) | 245.3K | ★ 2.0M |
| Earning Date | 05-07-2026 | 07-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 181.82 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $143,436,000.00 | N/A |
| Revenue This Year | $3.20 | N/A |
| Revenue Next Year | $7.31 | N/A |
| P/E Ratio | $177.80 | ★ N/A |
| Revenue Growth | ★ 6.36 | N/A |
| 52 Week Low | $5.43 | $3.76 |
| 52 Week High | $11.04 | $8.55 |
Technical Indicators
Market Signals| Indicator | INFU | HELP |
|---|---|---|
| Relative Strength Index (RSI) | 48.77 | 62.04 |
| Support Level | $8.51 | $4.18 |
| Resistance Level | $10.04 | $8.55 |
| Average True Range (ATR) | 0.37 | 0.54 |
| MACD | -0.06 | 0.05 |
| Stochastic Oscillator | 36.52 | 59.70 |
Price Performance
Historical ComparisonAbout INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
About HELP Cybin Inc. Common Stock
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.